Benoît Rousseau

18PUBLICATIONS

153CO-AUTHORS

Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 26, 2026

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

|Apr 21, 2026

Molecular lineages of sporadic mismatch-repair deficient colorectal cancer.

|Mar 27, 2026

POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Oct 30, 2025

Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.

Celine Yeh, Oliver Artz, Haochen Zhang

|Jul 10, 2025

Therapeutic targeting of mismatch repair-deficient cancers.

Paul Johannet, Benoit Rousseau, Carol Aghajanian

|Apr 11, 2025

Entering the Era of Multidimensional Prognostication for Personalized Risk Assessment in Stage III Colon Cancer.

Benoit Rousseau, Andrea Cercek

Pageof 3

Frequent Collaborators

Luis A Diaz

Michael B Foote

Guillem Argiles

Andrea Cercek

Henry Walch

Rona Yaeger

Nikolaus Schultz

Oliver Artz

Michael F Berger

Jinru Shia

Frequent Collaborators

Luis A Diaz

Michael B Foote

Guillem Argiles

Andrea Cercek